Female Stress Urinary Incontinence Treatment Devices Market – Global Industry Analysis, Growth, Trends and Forecast 2025

Latest Report on Female Stress Urinary Incontinence Treatment Devices Market Global Analysis & 2025 Forecast Research Study

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ — Global Female Stress Urinary Incontinence Treatment Devices Industry

Latest Report on Female Stress Urinary Incontinence Treatment Devices Market Global Analysis & 2025 Forecast Research Study

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Female Stress Urinary Incontinence Treatment Devices in these regions, from 2013 to 2025 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 
Global Female Stress Urinary Incontinence Treatment Devices market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
Johnson & Johnson 
Bard Medical 
American Medical Solutions 
Boston ScientificTeleflex 
Karl Storz and Coloplast 
… 

Try Sample Report @   https://www.wiseguyreports.com/sample-request/2964237-global-female-stress-urinary-incontinence-treatment-devices-market-research-report

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Silicones 
Polyurethane Foams 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Gynecology Clinic 
Hospitals 
Ambulatory Surgical Centers

Some points from table of content:

Global Female Stress Urinary Incontinence Treatment Devices Market Research Report 2018 
1 Female Stress Urinary Incontinence Treatment Devices Market Overview 
1.1 Product Overview and Scope of Female Stress Urinary Incontinence Treatment Devices 
1.2 Female Stress Urinary Incontinence Treatment Devices Segment by Type (Product Category) 
1.2.1 Global Female Stress Urinary Incontinence Treatment Devices Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Female Stress Urinary Incontinence Treatment Devices Production Market Share by Type (Product Category) in 2017 
1.2.3 Silicones 
1.2.4 Polyurethane Foams 
1.3 Global Female Stress Urinary Incontinence Treatment Devices Segment by Application 
1.3.1 Female Stress Urinary Incontinence Treatment Devices Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Gynecology Clinic 
1.3.3 Hospitals 
1.3.4 Ambulatory Surgical Centers 
1.4 Global Female Stress Urinary Incontinence Treatment Devices Market by Region (2013-2025) 
1.4.1 Global Female Stress Urinary Incontinence Treatment Devices Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Female Stress Urinary Incontinence Treatment Devices (2013-2025) 
1.5.1 Global Female Stress Urinary Incontinence Treatment Devices Revenue Status and Outlook (2013-2025) 
1.5.2 Global Female Stress Urinary Incontinence Treatment Devices Capacity, Production Status and Outlook (2013-2025)

2 Global Female Stress Urinary Incontinence Treatment Devices Market Competition by Manufacturers 
2.1 Global Female Stress Urinary Incontinence Treatment Devices Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Female Stress Urinary Incontinence Treatment Devices Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Female Stress Urinary Incontinence Treatment Devices Production and Share by Manufacturers (2013-2018) 
2.2 Global Female Stress Urinary Incontinence Treatment Devices Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Female Stress Urinary Incontinence Treatment Devices Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Female Stress Urinary Incontinence Treatment Devices Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Female Stress Urinary Incontinence Treatment Devices Market Competitive Situation and Trends 
2.5.1 Female Stress Urinary Incontinence Treatment Devices Market Concentration Rate 
2.5.2 Female Stress Urinary Incontinence Treatment Devices Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @     https://www.wiseguyreports.com/reports/2964237-global-female-stress-urinary-incontinence-treatment-devices-market-research-report

3 Global Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue (Value) by Region (2013-2018) 
3.1 Global Female Stress Urinary Incontinence Treatment Devices Capacity and Market Share by Region (2013-2018) 
3.2 Global Female Stress Urinary Incontinence Treatment Devices Production and Market Share by Region (2013-2018) 
3.3 Global Female Stress Urinary Incontinence Treatment Devices Revenue (Value) and Market Share by Region (2013-2018) 
3.4 Global Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.5 North America Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.6 Europe Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.7 China Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.8 Japan Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.9 Southeast Asia Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.10 India Female Stress Urinary Incontinence Treatment Devices Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Female Stress Urinary Incontinence Treatment Devices Supply (Production), Consumption, Export, Import by Region (2013-2018) 
4.1 Global Female Stress Urinary Incontinence Treatment Devices Consumption by Region (2013-2018) 
4.2 North America Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018) 
4.3 Europe Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018) 
4.4 China Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018) 
4.5 Japan Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018) 
4.6 Southeast Asia Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018) 
4.7 India Female Stress Urinary Incontinence Treatment Devices Production, Consumption, Export, Import (2013-2018)

5 Global Female Stress Urinary Incontinence Treatment Devices Production, Revenue (Value), Price Trend by Type 
5.1 Global Female Stress Urinary Incontinence Treatment Devices Production and Market Share by Type (2013-2018) 
5.2 Global Female Stress Urinary Incontinence Treatment Devices Revenue and Market Share by Type (2013-2018) 
5.3 Global Female Stress Urinary Incontinence Treatment Devices Price by Type (2013-2018) 
5.4 Global Female Stress Urinary Incontinence Treatment Devices Production Growth by Type (2013-2018)

6 Global Female Stress Urinary Incontinence Treatment Devices Market Analysis by Application 
6.1 Global Female Stress Urinary Incontinence Treatment Devices Consumption and Market Share by Application (2013-2018) 
6.2 Global Female Stress Urinary Incontinence Treatment Devices Consumption Growth Rate by Application (2013-2018) 
6.3 Market Drivers and Opportunities 
6.3.1 Potential Applications 
6.3.2 Emerging Markets/Countries

Continued…….

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Healthcare Exoskeletons Market Segment by Applications, Manufacturers, Regions and Forecast to 2023

WiseGuyReports.Com Publish a New Market Research Report On–“ Healthcare Exoskeletons Market Segment by Applications, Manufacturers, Regions and Forecast 2023”

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

Description:

During 2017-2023, global demand for healthcare exoskeletons is poised to a cumulative market value of over $2.49 billion including direct sales, renting, leasing, insurance reimbursement and other revenue sources. In terms of unit shipment from direct sales, the global total market over 2017-2023 is expected to reach 27,180 units, representing an exponential CAGR over the forecast years.

Global Healthcare Exoskeletons Market 2016-2023: Structure Analysis, Trend Outlook and Business Strategy is based on a comprehensive research of the healthcare exoskeletons market by analyzing the entire global market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
In-depth qualitative analyses include identification and investigation of market structure, growth drivers, restraints and challenges, emerging product trends & market opportunities, Porter’s Fiver Forces, partnership and fundraising landscape. Moreover, risks associated with investing in global healthcare exoskeletons market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders manage and minimize the risks, develop appropriate business models, and make wise decisions.

The report quantifies global healthcare exoskeletons market in every aspect of the classification from perspectives of application, mobility type, product function, power technology and region.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/910124-global-healthcare-exoskeletons-market-and-business-strategy

For more information or any query mail at sales@wiseguyreports.com

Based on application, the global market is segmented into the following sections with annual revenue data available for each section over 2014-2023:
• Rehabilitation
• Mobility Aid
• Other Applications

On basis of mobility type, the global market is studied in the following segments with annual revenue data provided for each sub-segment covering 2014-2023:
• Mobile Exoskeletons
• Stationary Exoskeletons
• Tethered Exoskeletons

On basis of product function, the global market is studied in the following segments with annual revenue available for each sub-segment covering 2014-2023:
• Upper Body Exoskeletons
• Lower Body Exoskeletons

On basis of power technology, the global market is segmented into the following sections with annual revenue forecast for each section covering 2014-2023:
• Active Exoskeletons (by power type, this section is further classified into Electric Actuator, Pneumatic Actuator, Hydraulic Actuator, Fuel Cell, and Others)
• Passive Exoskeletons

Geographically, the following five regions together with the listed leading national markets are fully investigated:
• APAC (China, Japan, South Korea, Australia, India, and Rest of APAC)
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
• North America (U.S. and Canada)
• Latin America
• RoW
For each of the aforementioned regions and countries, detailed analysis and data about annual revenue of healthcare exoskeletons are available for every single year over 2014-2023.

The report also includes global annual shipment 2014-2023 based on direct sales, the split of global revenue by revenue mode over the forecast years, average selling price of healthcare exoskeletons for 2014-2023, current competitive scenario and the predicted manufacture trend, and profiles 12 healthcare exoskeleton vendors including market leaders and important emerging players.

Highlighted with 22 tables and 68 figures, this 141-page report provides timely data and detailed analysis to help clients targeting the global market to identify business opportunities and benchmark effective strategies.

Report Details @ https://www.wiseguyreports.com/reports/910124-global-healthcare-exoskeletons-market-and-business-strategy

Table Of Contents – Major Key Points

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Qualitative Analysis
2.1 Market Structure
2.2 Market Size and Forecast
2.3 Major Growth Drivers
2.4 Market Restraints and Challenges
2.5 Emerging Opportunities and Market Trends
2.6 Porter’s Fiver Forces Analysis
2.7 Investing in Global Market: Risk Assessment and Management
2.7.1 Risk Evaluation of Global Market
2.7.2 Critical Success Factors (CSFs)

3 Segmentation of Global Market by Application
3.1 Market Overview by Application
3.2 Global Rehabilitation Exoskeletons Market 2014-2023
3.3 Global Mobility Aid Exoskeletons Market 2014-2023
3.4 Global Market of Healthcare Exoskeletons in Other Applications 2014-2023

4 Segmentation of Global Market by Mobility Type
4.1 Market Overview by Mobility Type
4.2 Global Mobile Healthcare Exoskeletons Market 2014-2023
4.3 Global Stationary Healthcare Exoskeletons Market 2014-2023
4.4 Global Tethered Healthcare Exoskeletons Market 2014-2023

5 Segmentation of Global Market by Product Function
5.1 Market Overview by Product Function
5.2 Global Upper Body Healthcare Exoskeletons Market 2014-2023
5.3 Global Lower Body Healthcare Exoskeletons Market 2014-2023

6 Segmentation of Global Market by Power Technology
6.1 Market Overview by Power Technology
6.2 Global Active Healthcare Exoskeletons Market 2014-2023
6.2.1 Global Market of Active Healthcare Exoskeletons with Electric Actuators 2014-2023
6.2.2 Global Market of Active Healthcare Exoskeletons with Pneumatic Actuators 2014-2023
6.2.3 Global Market of Active Healthcare Exoskeletons with Hydraulic Actuators 2014-2023
6.2.4 Global Market of Active Healthcare Exoskeletons with Fuel Cells 2014-2023
6.2.5 Global Market of Active Healthcare Exoskeletons with Other Power Technology 2014-2023
6.3 Global Passive Healthcare Exoskeletons Market 2014-2023

7 Segmentation of Global Market by Region
7.1 Geographic Market Overview by Region 2016-2023
7.2 North America Market 2014-2023
7.2.1 Overview of North America Market
7.2.2 U.S. Market
7.2.3 Canadian Market
7.3 European Market 2014-2023
7.3.1 Overview of European Market
7.3.2 Germany
7.3.3 France
7.3.4 UK
7.3.5 Italy
7.3.6 Spain
7.3.7 Rest of European Market
7.4 Asia-Pacific Market 2014-2023
7.4.1 Overview of Asia-Pacific Market
7.4.2 Japan
7.4.3 China
7.4.4 South Korea
7.4.5 Australia
7.4.6 India
7.4.7 Rest of APAC Region
7.5 Latin America Market 2014-2023
7.6 Rest of World Market 2014-2023

Continue……

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Pharmacy Automation Systems 2018 Market By: Industry Size,Growth,Analysis,Opportunities, and Forecasts to 2025

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ — WiseGuyReports.Com Publish a New Market Research Report On –“ Pharmacy Automation Systems 2018 Market By: Industry Size,Growth,Analysis,Opportunities, and Forecasts to 2025”.

Description:

Patient safety is a top priority in hospital and retail pharmacies. Over and beyond the forecast period, an increasing adoption of pharmacy automation systems is expected in a global scope because these systems can reduce medication errors and improve workflow efficiency in pharmacies. Global total sales revenue of pharmacy automation systems will advance to $XXX billion in 2025, registering a CAGR of 7.0% between 2016 and 2025. This represents a cumulative revenue of $XXX billion during 2017-2025 owing to a substantial adoption of automated medication dispensing systems, automated storage and retrieval systems, automated packaging and labeling systems, table-top tablet counters, and automated drug compounding devices in hospital pharmacies, retail drug stores and other types of pharmacies across the globe.

Highlighted with 60 tables and 69 figures, this 184-page report “Global Pharmacy Automation Systems Market 2017-2025 by End-user, Product and Region” is based on a comprehensive research of worldwide pharmacy automation systems market by analyzing the entire global market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2014 and 2015, revenue estimates for 2016, and forecasts from 2017 till 2025.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2427734-global-pharmacy-automation-systems-market-2017-2025-by-end-user-product-and-region

For more information or any query mail at sales@wiseguyreports.com

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global pharmacy automation systems market in every aspect of the classification from perspectives of end-user, product type and region.

Based on end-users, the global market is segmented into the following sub-markets with annual revenue included for 2014-2025 (historical and forecast) for each section.

• Hospital Pharmacies (further segmented into Hospital Inpatient Pharmacy and Hospital Outpatient Pharmacy)
• Retail Pharmacies (further divided into Retail Chain Pharmacies and Independent Drug Stores)
• Pharmacy Benefit Management Organizations
• Others

Based on product type, the global market is analyzed on the following segments with annual revenue in 2014-2025 provided for each segment.
• Automated Medication Dispensing Systems (further categorized into Centralized Systems (Robotic Systems and Carousels) and Decentralized Systems (Automated Unit-Dose Dispensing Systems, Pharmacy-Based Automated Dispensing Systems, Ward-Based Automated Dispensing Systems )

• Automated Storage and Retrieval Systems
• Automated Packaging and Labeling Systems (further divided into Unit-Dose Packaging & Labeling Systems and Multi-Dose Packaging & Labeling Systems)
• Table-top Tablet Counters
• Automated Drug Compounding Devices (further segmented into Compounding Systems for Solid Formulation, Compounding Systems for Liquid Formulation, Compounding Systems for Other Formulations)
• Others

Geographically, the following regions together with the listed national markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC)
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
• North America (U.S. and Canada)
• Latin America (Argentina, Brazil, Mexico, Rest of Latin America)
• RoW

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2014-2025. The breakdown of all regional markets and key national markets by end-user and product type over the forecast years is included.

The report also covers current competitive scenario and the predicted manufacture trend; and profiles global pharmacy automation systems vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmacy automation systems market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Report Details @ https://www.wiseguyreports.com/reports/2427734-global-pharmacy-automation-systems-market-2017-2025-by-end-user-product-and-region

Table Of Contents – Major Key Points

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15

2 Market Overview and Qualitative Analysis 17
2.1 Market Size and Forecast 17
2.2 Market Structure 19
2.3 Major Growth Drivers 20
2.4 Market Restraints and Challenges 25
2.5 Emerging Opportunities and Market Trends 28
2.6 Porter’s Fiver Forces Analysis 32

3 Analysis of Global Market by End-user 36
3.1 Market Overview by End-user 36
3.2 Hospital Pharmacies 39
3.3 Retail Pharmacies 44
3.4 Pharmacy Benefit Management Organizations 48
3.5 Other End-users 50

4 Analysis of Global Market by Product 51
4.1 Market Overview by Product 51
4.2 Automated Medication Dispensing Systems (AMDS) 54
4.2.1 Centralized Automated Medication Dispensing Systems 58
4.2.2 Decentralized Automated Medication Dispensing Systems 60
4.3 Automated Storage and Retrieval Systems 62
4.4 Automated Packaging and Labeling Systems 63
4.5 Table-top Tablet Counters 65
4.6 Automated Drug Compounding Devices 68
4.7 Other Pharmacy Automation Systems 70

5 Analysis of Global Market by Region 72
5.1 Geographic Market Overview by Region 2016-2025 72
5.2 North America Market 2014-2025 80
5.2.1 Overview of North America Market 80
5.2.2 U.S. Market 84
5.2.3 Canadian Market 87
5.3 European Market 2014-2025 89
5.3.1 Overview of European Market 89
5.3.2 Germany 93
5.3.3 France 95
5.3.4 UK 97
5.3.5 Italy 99
5.3.6 Spain 101
5.3.7 Rest of European Market 103
5.4 Asia-Pacific Market 2014-2025 104
5.4.1 Overview of Asia-Pacific Market 104
5.4.2 Japan 108
5.4.3 China 111
5.4.4 South Korea 113
5.4.5 Australia 115
5.4.6 India 117
5.4.7 Rest of APAC Region 119

Continue……

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Infertility Drugs 2018 Global Market Expected to Grow at CAGR 4.67 % and Forecast to 2022

Wise.Guy12

Wise.Guy.

WiseGuyReports.com adds “Global Infertility Drugs Market 2018-2022” reports to its Database.

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

About Infertility Drugs

Infertility can be defined as an inability of a person to reproduce through natural means. Infertility can occur in any of the two genders, i.e., male and female.

Technavio’s analysts forecast the global infertility drugs market to grow at a CAGR of 4.67% during the period 2018-2022.

Covered in this report 
The report covers the present scenario and the growth prospects of the global infertility drugs market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio's report, Global Infertility Drugs Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Bayer 
• Ferring 
• Merck 
• Novartis

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2963418-global-infertility-drugs-market-2018-2022                       

Market driver 
• Growing lifestyle diseases 
• For a full, detailed list, view our report

Market challenge 
• Rising inclination toward other modes of treatment for infertility 
• For a full, detailed list, view our report

Market trend 
• Raising awareness regarding infertility in couples 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2022 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents:                                                                                                                          

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: INTRODUCTION 
• Introduction 
• Diagnosis and treatment 
PART 05: MARKET LANDSCAPE 
• Market ecosystem 
• Market characteristics 
• Market segmentation analysis 
PART 06: MARKET SIZING 
• Market definition 
• Market sizing 
• Market size and forecast 
PART 07: FIVE FORCES ANALYSIS 
• Bargaining power of buyers 
• Bargaining power of suppliers 
• Threat of new entrants 
• Threat of substitutes 
• Threat of rivalry 
• Market condition 
PART 08: PIPELINE ANALYSIS 
PART 09: MARKET SEGMENTATION BY THERAPY 
• Segmentation by therapy 
• Comparison by therapy 
• Global hormone-based therapy market 
• Global others market 
• Market opportunity by therapy 
PART 10: MARKET SEGMENTATION BY GENDER 
• Segmentation by gender 
• Global female infertility drugs market 
• Global male infertility drugs market 
PART 11: CUSTOMER LANDSCAPE 
PART 12: REGIONAL LANDSCAPE 
• Geographical segmentation 
• Regional comparison 
• Infertility drugs market in Americas 
• Infertility drugs market in EMEA 
• Infertility drugs market in APAC 
• Market opportunity 
PART 13: DECISION FRAMEWORK 
PART 14: DRIVERS AND CHALLENGES 
• Market drivers 
• Market challenges 
PART 15: MARKET TRENDS 
• Raising awareness regarding infertility in couples 
• Growing online retail sales of drugs 
PART 16: VENDOR LANDSCAPE 
• Overview 
• Landscape disruption 
PART 17: VENDOR ANALYSIS 
• Vendors covered 
• Vendor classification 
• Market positioning of vendors 
• Bayer 
• Ferring 
• Merck 
• Novartis 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/2963418-global-infertility-drugs-market-2018-2022                             

 

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Hearing Implants 2018 Global Market Expected to Grow at CAGR 9.73 % and Forecast to 2022

Wise.Guy12

Wise.Guy.

WiseGuyReports.com adds “Global Hearing Implants Market 2018-2022” reports to its Database.

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

About Hearing Implants 
Hearing implants are used when the normal function of the inner ear is damaged. These devices send sound signals artificially to the brain of the patients with severe hearing impairment to help them hear.

Technavio’s analysts forecast the global hearing implants market to grow at a CAGR of 9.73% during the period 2018-2022.

Covered in this report 
The report covers the present scenario and the growth prospects of the global hearing implants market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of hearing implants.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio's report, Global Hearing Implants Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Cochlear 
• MED-EL 
• Sonova 
• William Demant

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2963443-global-hearing-implants-market-2018-2022                     

Market driver 
• Increasing prevalence of hearing loss 
• For a full, detailed list, view our report

Market challenge 
• High cost of hearing implants 
• For a full, detailed list, view our report

Market trend 
• Increasing focus on emerging markets 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2022 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents:                                                                                                                          

PART 01: EXECUTIVE SUMMARY 
PART 02: SCOPE OF THE REPORT 
PART 03: RESEARCH METHODOLOGY 
PART 04: MARKET LANDSCAPE 
• Market ecosystem 
• Market characteristics 
• Market segmentation analysis 
PART 05: MARKET SIZING 
• Market definition 
• Market sizing 2017 
• Market size and forecast 2017-2022 
PART 06: FIVE FORCES ANALYSIS 
• Bargaining power of buyers 
• Bargaining power of suppliers 
• Threat of new entrants 
• Threat of substitutes 
• Threat of rivalry 
• Market condition 
PART 07: MARKET SEGMENTATION BY PRODUCT TYPE 
• Overview 
• Comparison by product type 
• Global cochlear implants market 
• Global BAHA market 
• Global other hearing implants market 
• Market opportunity by product type 
PART 08: CUSTOMER LANDSCAPE 
PART 09: REGIONAL LANDSCAPE 
• Overview 
• Regional comparison 
• Hearing implants market in Americas 
• Hearing implants market in EMEA 
• Hearing implants market in APAC 
• Key leading countries 
• Market opportunity 
PART 10: DECISION FRAMEWORK 
PART 11: DRIVERS AND CHALLENGES 
• Market drivers 
• Market challenges 
PART 12: MARKET TRENDS 
• Emerging technological innovations 
• Increasing focus on emerging markets 
PART 13: VENDOR LANDSCAPE 
• Overview 
• Landscape disruption 
• Vendor landscape 
PART 14: VENDOR ANALYSIS 
• Vendors covered 
• Vendor classification 
• Market positioning of vendors 
• Cochlear 
• MED-EL 
• Sonova 
• William Demant 
• Other prominent vendors 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/2963443-global-hearing-implants-market-2018-2022                           

 

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Baobab Powder 2018 Global Market Expected to Grow at CAGR of 6.47% and Forecast to 2022

Wiseguyreports.Com Publish Market Research Report On -“Baobab Powder Market – Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2023”

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

Baobab Powder Market 2018

Baobab powder is made from a super fruit called Baobab, which is also a rich source of vitamin C, calcium, and magnesium. It is consumed to boost health and vitality. The powder can be used as a health supplement and as a food ingredient. A natural source of dietary fibers, minerals and organic acids, Baobab powder also has antioxidant and prebiotic properties.

The analysts forecast the global baobab powder market to grow at a CAGR of 6.47% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global baobab powder market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of baobab powder.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2963408-global-baobab-powder-market-2018-2022

The report, Global Baobab Powder Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Halka B Organics
• Baobab Fruit Company Senegal
• Organic Africa
• ADUNA
• Atacora Essential
• Woodland Foods

Market driver
• Health benefits of baobab powder
• For a full, detailed list, view our report

Market challenge
• Growing popularity of substitutes
• For a full, detailed list, view our report

Market trend
• Growing popularity of baobab supplements
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

Complete Report Details @ https://www.wiseguyreports.com/reports/2963408-global-baobab-powder-market-2018-2022

Table of Contents –Analysis of Key Points

PART 01:EXECUTIVE SUMMARY
PART 02:SCOPE OF THE REPORT
PART 03:RESEARCH METHODOLOGY
• Market outline

PART 04:MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05:MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06:FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07:MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Food – Market size and forecast 2017-2022
• Beverages – Market size and forecast 2017-2022
• Personal care – Market size and forecast 2017-2022
• Market opportunity by application

PART 08:CUSTOMER LANDSCAPE
PART 09:REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• EMEA – Market size and forecast 2017-2022
• Americas – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• US
• Germany
• The UK
• France
• Market opportunity

PART 10:DECISION FRAMEWORK
PART 11:DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12:MARKET TRENDS
• Growing popularity of baobab supplements
• Increasing online purchasing trends
• Clean labeling

PART 13:VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14:VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Halka B Organics
• Baobab Fruit Company Senegal
• Organic Africa
• ADUNA
• Atacora Essential
• Woodland Foods
..…..Continued

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Operational Technology Market 2018 – Industry Trends, Opportunities and Forecasts to 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ — In this report, the global Operational Technology market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Operational Technology in these regions, from 2013 to 2025 (forecast), covering
United States
EU
China
Japan
South Korea
Taiwan

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2867379-global-operational-technology-market-research-report-2018

Global Operational Technology market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
SAP SE
IBM Limited
Cisco Systems
Oracle
Huawei Technologies
Hewlett-Packard Enterprise
NEC Corporation
Cognizant
Accenture
Wipro

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Wired Technology
Wireless Technology

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Process Industry
Non-Process Industry

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Operational Technology Market Research Report 2018
1 Operational Technology Market Overview
1.1 Product Overview and Scope of Operational Technology
1.2 Operational Technology Segment by Type (Product Category)
1.2.1 Global Operational Technology Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Operational Technology Production Market Share by Type (Product Category) in 2017
1.2.3 Wired Technology
1.2.4 Wireless Technology
1.3 Global Operational Technology Segment by Application
1.3.1 Operational Technology Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Process Industry
1.3.3 Non-Process Industry
1.4 Global Operational Technology Market by Region (2013-2025)
1.4.1 Global Operational Technology Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 United States Status and Prospect (2013-2025)
1.4.3 EU Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 South Korea Status and Prospect (2013-2025)
1.4.7 Taiwan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Operational Technology (2013-2025)
1.5.1 Global Operational Technology Revenue Status and Outlook (2013-2025)
1.5.2 Global Operational Technology Capacity, Production Status and Outlook (2013-2025)

2 Global Operational Technology Market Competition by Manufacturers
2.1 Global Operational Technology Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Operational Technology Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Operational Technology Production and Share by Manufacturers (2013-2018)
2.2 Global Operational Technology Revenue and Share by Manufacturers (2013-2018)
2.3 Global Operational Technology Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Operational Technology Manufacturing Base Distribution, Sales Area and Product Type
2.5 Operational Technology Market Competitive Situation and Trends
2.5.1 Operational Technology Market Concentration Rate
2.5.2 Operational Technology Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Operational Technology Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Operational Technology Capacity and Market Share by Region (2013-2018)
3.2 Global Operational Technology Production and Market Share by Region (2013-2018)
3.3 Global Operational Technology Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 United States Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 EU Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 South Korea Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 Taiwan Operational Technology Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Operational Technology Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Operational Technology Consumption by Region (2013-2018)
4.2 United States Operational Technology Production, Consumption, Export, Import (2013-2018)
4.3 EU Operational Technology Production, Consumption, Export, Import (2013-2018)
4.4 China Operational Technology Production, Consumption, Export, Import (2013-2018)
4.5 Japan Operational Technology Production, Consumption, Export, Import (2013-2018)
4.6 South Korea Operational Technology Production, Consumption, Export, Import (2013-2018)
4.7 Taiwan Operational Technology Production, Consumption, Export, Import (2013-2018)

5 Global Operational Technology Production, Revenue (Value), Price Trend by Type
5.1 Global Operational Technology Production and Market Share by Type (2013-2018)
5.2 Global Operational Technology Revenue and Market Share by Type (2013-2018)
5.3 Global Operational Technology Price by Type (2013-2018)
5.4 Global Operational Technology Production Growth by Type (2013-2018)

6 Global Operational Technology Market Analysis by Application
6.1 Global Operational Technology Consumption and Market Share by Application (2013-2018)
6.2 Global Operational Technology Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

……Continued

Make an enquiry of this Report @ https://www.wiseguyreports.com/enquiry/2867379-global-operational-technology-market-research-report-2018

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Eye Care Surgical Devices 2018 Global Market Expected to Grow at CAGR of 7.57% and Forecast to 2022

Wiseguyreports.Com Publish Market Research Report On -“Eye Care Surgical Devices Market – Global Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2023”

PUNE, INDIA, February 9, 2018 /EINPresswire.com/ —

Eye Care Surgical Devices Market 2018

Eye care surgical devices are used to treat eye disorders such as cataract, glaucoma, diabetic retinopathy, diabetic macular edema, and other eye-related surgical disorders.

The analysts forecast the global eye care surgical devices market to grow at a CAGR of 7.57% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global eye care surgical devices market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2924226-global-eye-care-surgical-devices-market-2018-2022

The report, Global Eye Care Surgical Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Carl Zeiss Meditec
• Johnson & Johnson
• Novartis
• TOPCON
• Valeant Pharmaceuticals

Market driver
• High incidence of eye diseases
• For a full, detailed list, view our report

Market challenge
• Potential risk of complications with laser procedures
• For a full, detailed list, view our report

Market trend
• Availability of advanced technology
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

Complete Report Details @ https://www.wiseguyreports.com/reports/2924226-global-eye-care-surgical-devices-market-2018-2022

Table of Contents –Analysis of Key Points

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Cataract Surgery – Market size and forecast 2017-2022
• Glaucoma surgery – Market size and forecast 2017-2022
• Diabetic eye surgery – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Availability of advanced technology
• Shift toward ASCs for eye care
• Availability of advanced IOLs implants

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Carl Zeiss Meditec
• Novartis
• Valeant Pharmaceuticals
• TOPCON
• Johnson & Johnson
..…..Continued

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

McKay-Dee Hospital Orthopedic Surgeon, Physical Therapist Provide Medical Support at 2018 Winter Olympics

SALT LAKE CITY, UTAH, USA, February 8, 2018 /EINPresswire.com/ — Dr. Jeff Harrison, an orthopedic surgeon and Sports Medicine Director at Intermountain McKay-Dee Orthopedics and Sports Medicine, is the Head Team Physician for the U.S. Women’s Alpine Ski Team and will be representing the United States as medical staff during the 2018 Winter Olympics in Pyeongchang, South Korea.

Doug Flint, a physical therapist at Intermountain McKay-Dee Sports Medicine, is also traveling to South Korea to provide medical support for Sweden and Norway’s moguls teams during the Winter Games.

As the Head Team Physician, Dr. Harrison will help ensure Olympic Medal hopefuls like Lindsey Vonn and Mikaela Shiffrin stay healthy throughout the Winter Olympics. He will oversee all medical care for the ten women on the U.S. Alpine Ski Team. He will also evaluate and treat injuries on the hill if the need arises, but hopes that the athletes complete all their runs safely.

Dr. Harrison has been a member of the U.S. Ski and Snowboard Association physician pool since 1998, and he is an expert orthopedic surgeon specializing in knee and shoulder surgery at home. Dr. Harrison has provided medical care to world-class athletes on and off the slopes for years. He has lent his medical expertise to five world championships and served as the Venue Medical Officer at Snowbasin Resort during the 2002 Winter Olympics in Utah.

“I’m looking forward to going to South Korea,” Dr. Harrison said. “I’ve never been to Asia, so that’s going to be exciting. Ski races are all somewhat similar, but I think the cultural exchange is what I’m looking forward to most.”

“It will also be exciting because the U.S. is going to have a really good team this year with Mikaela and Lindsey,” Harrison continued. “I think we’re going to win some medals.”

In addition to Shiffrin and Vonn, Dr. Harrison also said to keep an eye out for Breezy Johnson and Stacey Cook, who each have a good shot at medaling this year.

Doug Flint, a physical therapist at Intermountain Sports Medicine McKay-Dee Hospital, is also traveling to South Korea for the Winter Olympics. He is team physiotherapist for Sweden and Norway’s moguls teams and keeps those athletes healthy and conditioned to compete for their nations.

Flint is responsible for assessing and managing injuries, but devotes a great deal of his effort to preventing those injuries through proper warm ups, custom workouts, and proper exercise recovery.

“On competition days, I take care of last-minute physical issues, check equipment, and fit them into their skis properly,” said Flint. “I also assist the head coach at the starting line with any other issues that come up.”

Flint has worked as a physical therapist with many teams throughout his career. He has worked with the U.S., Sweden, Norway, and many other countries throughout 40 World Cup events, four World Championships, and now two Olympic Games.

During the 2018 Olympics, Flint recommends keeping an eye out for Hedvig Wessel and Vinjar Slatten from Norway and Ludwig Fjalstrom from Sweden, who has recovered from a surgical A.C.L. repair well in just ten months.

Though Flint and Dr. Harrison are providing medical expertise at the Olympic Games, they work very closely with local athletes of all abilities. When asked about everyday skiers staying safe on the slopes, Dr. Harrison said:

“Fitness level is very important. Also, there are ways to fall that are better than others. If you fall forward instead of backward, you have a better chance at avoiding an ACL tear.”

Dr. Harrison also emphasized fitting equipment properly, not using old equipment, and wearing a helmet to reduce your risk of injury.

Both Intermountain caregivers are excited for the opportunity to care for some of the world’s top athletes during the 2018 Olympics. With an excellent snowpack and cold winter weather, South Korea’s Winter Games will make for gripping competition.

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, a Medical Group with 180 clinics and 1,500 employed physicians and clinicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit IntermountainHealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018

PLASTEC West Anaheim 2018

Carotid Stenotic Scan (CSS)

CVR Medical Corp. (OTCQB:CRRVF)

VANCOUVER, BRITISH COLUMBIA, CANADA, February 8, 2018 /EINPresswire.com/ —

CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical” or “CVR”) has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 – 8, 2018), the largest domestic conference and expo for advanced design and manufacturing of plastics technologies. CVI, subsidiary of Canon U.S.A., Inc, is the sole manufacturer of the cart for CVR Medical’s “Carotid Stenotic Scan (CSS)” device.

CVI is sharing a booth with CVR at the event, highlighting abilities that allow for the unique, customized manufacturing of the CSS, as well as logistics and product support needs. The partnership, announced in 2017, established the production pathway through which the CSS will be launched later this year. PLASTEC West draws over 20,000 engineers, executives, and industry luminaries, providing invaluable brand exposure for both companies that are presenting ground-breaking solutions in manufacturing and medicine.

CVR COO Tony Robinson states, “We are excited to attend [PLASTEC West] and show off the results from what has been an incredible partnership. Working with CVI to create the best possible design, and have it manufactured with a streamlined supply chain, has made it possible for us to aim for our highest goals. They have set a new industry quality standard, and we’re proud to reflect that with our device.”

For additional information on the organization, leadership, and current news, please visit the company’s website www.CVRMed.com.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the "Joint Venture"). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

ON BEHALF OF THE BOARD:
(signed) "Peter Bakema"
CEO, President & Director

For further information contact:

Peter Bakema, CEO, President and Director
Telephone: (734) 718-5115
Email: info@cvrmed.com
or
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Peter Bakema
CVR Medical Corp.
734-718-5115
email us here


Source: EIN Presswire